ATE165514T1 - Verwendung von inosittriphosphat zur zubereitung von medikamenten - Google Patents

Verwendung von inosittriphosphat zur zubereitung von medikamenten

Info

Publication number
ATE165514T1
ATE165514T1 AT91912558T AT91912558T ATE165514T1 AT E165514 T1 ATE165514 T1 AT E165514T1 AT 91912558 T AT91912558 T AT 91912558T AT 91912558 T AT91912558 T AT 91912558T AT E165514 T1 ATE165514 T1 AT E165514T1
Authority
AT
Austria
Prior art keywords
inosite
triphosphate
preparing
preparing medications
medications
Prior art date
Application number
AT91912558T
Other languages
English (en)
Inventor
Matti Siren
Lars Edvinsson
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Application granted granted Critical
Publication of ATE165514T1 publication Critical patent/ATE165514T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91912558T 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten ATE165514T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002278A SE9002278L (sv) 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Publications (1)

Publication Number Publication Date
ATE165514T1 true ATE165514T1 (de) 1998-05-15

Family

ID=20379887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912558T ATE165514T1 (de) 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten

Country Status (10)

Country Link
US (1) US5284839A (de)
EP (2) EP0554861A1 (de)
JP (1) JPH0639383B2 (de)
AT (1) ATE165514T1 (de)
AU (1) AU8188691A (de)
DE (1) DE69129331T2 (de)
DK (1) DK0536269T3 (de)
ES (1) ES2115616T3 (de)
SE (1) SE9002278L (de)
WO (1) WO1992000079A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213215D0 (en) * 1992-06-20 1992-08-05 Wellcome Found Peptides
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
WO1995005830A1 (en) * 1993-08-20 1995-03-02 The Regents Of The University Of California Polyanion anti-inflammatory agents
US5516653A (en) 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5989920A (en) 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
CN1135983C (zh) * 2001-06-28 2004-01-28 中山大学 二酸（5－雄甾烯－17－酮－3β－羟基）二酯用于制备药物
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
JP2005514008A (ja) * 2001-09-24 2005-05-19 オレゴン ヘルス アンド サイエンス ユニバーシティー 摂食行動を改変する薬剤をスクリーニングするための、弓状核におけるニューロンの評価方法
AU2002332054B2 (en) * 2001-09-24 2007-11-08 Imperial Innovations Limited Modification of feeding behavior
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
WO2003057235A2 (en) 2002-01-10 2003-07-17 Imperial College Innovations Ltd Modification of feeding behavior
KR20040051455A (ko) * 2002-12-12 2004-06-18 아미코젠주식회사 산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
GB0300571D0 (en) * 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
CN102573853A (zh) * 2009-07-07 2012-07-11 诺尔姆奥克西斯公司 使用肌醇三焦磷酸减少多药抗性的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel

Also Published As

Publication number Publication date
US5284839A (en) 1994-02-08
DK0536269T3 (da) 1998-10-07
ES2115616T3 (es) 1998-07-01
WO1992000079A1 (en) 1992-01-09
AU8188691A (en) 1992-01-23
DE69129331T2 (de) 1998-09-24
EP0554861A1 (de) 1993-08-11
JPH0639383B2 (ja) 1994-05-25
EP0536269B1 (de) 1998-04-29
JPH04230220A (ja) 1992-08-19
SE9002278L (sv) 1991-12-29
DE69129331D1 (de) 1998-06-04
EP0536269A1 (de) 1993-04-14
SE9002278D0 (sv) 1990-06-28

Similar Documents

Publication Publication Date Title
ATE165514T1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
PT97638A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ATE121295T1 (de) Augentropfenarzneimittel.
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
DE59200277D1 (de) Substituierte Diaminophthalimide und Analoga.
ATE101594T1 (de) Einen zink-komplex enthaltende arzneimittel.
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
NO882559L (no) Transdermalt leveringssystem for farmasoeytiske forbindelser.
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
DE69808287D1 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
DE68901656D1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
ATE118221T1 (de) Verwendung von tumornekrosefaktor.
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
IT9019002A1 (it) Composti otticamente attivi per la profilassi dell'insufficienza coronarica acuta e cronica, loro preparazione e composizioni farmaceutiche che li contengono
ITMI911335A0 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
ITMI911444A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee